Conversely, inhibiting a branch of the polyamine pathway can also lead to tissue protection against multiple models of kidney diseases (e.g., inhibition of ornithine decarboxylase or eukaryotic translation initiation factor 5A hypusination) (15, 16, 30–32). Here, ODC1 is linked to kidney disorder.